Giant cell arteritis: Oral versus intravenous corticosteroids

Neuro-Ophthalmology

Volumn 33, Issue 1-2, 2009, Pages 5-9

  Tehrani, Rodney ^a   Ostrowski, Rochella A ^a   Hariman, Richard ^a   Jay, Walter M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Corticosteroids; Giant cell arteritis; Polymyalgia rheumatica; Temporal arteritis; Vasculitis

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ABDOMINAL TUMOR; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CUSHINGOID SYNDROME; DRUG MECHANISM; GASTROINTESTINAL DISEASE; GIANT CELL ARTERITIS; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; LUNG EDEMA; OSTEOPOROSIS; REVIEW; STROKE; UNSTABLE ANGINA PECTORIS; VISUAL IMPAIRMENT;

EID: 67650797236     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.1080/01658100802716754     Document Type: Review

References (19)

1. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis and polymyalgia rheumatica in a Danish county. Arthritis Rheum. 1987;30:292-299
2. Healey A. Relation of giant cell arteritis to polymyalgia rheumatica. In: Bailliere's Clinical Rheumatology, Hazelman BL, Bengtsson B.-A., eds. London: Bailliere Tindall,1991: pp. 372-373
3. Bengtsson B.-A. Epidemiology of giant cell arteritis. In:Bailliere's Clinical Rheumatology, Hazelman BL, Bengtsson B.-A., eds. London: Bailliere Tindall, 1991: pp. 380-383
4. Lam BL, Wirthlin RS, Gonzalez A, Dubovy SR, Feuer WJ. Giant cell arteritis among Hispanic Americans. Am J Opthalmol. 2007 Jan;143(1):161-163 (Pubitemid 44917810)
5. Loddenkemper T, Sharma P, Katzan I, Plant GT. Risk factors for early visual deterioration in giant cell arteritis. J Neurol Neurosurg Psychiatry. 2007;78:1255-1259
6. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors, and a conformational ensemble model. Nature Rev Drug Discovery. 2004;3:27-41.
7. Speira RF, Mitnick HF, Kupersmith M, Richmond M, Spiera H, Peterson MG et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol. 2001;19:495-501. (Pubitemid 32894598)
8. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, et al. for the International Network for the Study of Systemic Vasculitides (INSSYS). A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318
9. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, BanaresA, Fernandez-Gutierrez B. Combined treatment of giant cell arteritis with methotrexate and prednisone: A randomized, doubleblind, placebo-controlled trial. Ann Intern Med. 2001;134:106-114 (Pubitemid 32096337)
10. Hayreh SS. Steroid therapy for visual loss in patientswith giantcell arteritis. Lancet. 2000;3555:1572-1573.
11. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204-1215. (Pubitemid 36676655)
12. Spiera RF, Spiera H. Therapy for giant cell arteritis: Can we do better? Arthritis Rheum. 2006;54:3071-3074.
13. Mazlumzadeh M, Hunder GG, Easeley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids. Arth Rheum. 2006;54:3310-3318.
14. Hall JK, Balcer LJ. Giant cell arteritis. Curr Treat OptNeurol. 2004;6:45-53.
15. Carroll SC, Gaskin BJ, Danesh-Meyer HV. Clin Exper Ophthalmol. 2006; 34:159-173.
16. Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter controlled trial using intravenous pulses of methyprednisolone in the initial treatment of simple forms of giant cell arteritis: A one year follow-up study of 164 patients.J Rheumatol. 2000;27(6):1484-1491.
17. Sailler L, Carreiro M, Ollier S, Juchet H, Delobel P, Ferrand D, Klinger M, Arlet P. Non-complicated Horton's disease: Initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20mg/day prednisone-equivalent. Evaluation of 15 patients. Revue de Medecine Interne 2001;22:1032-1038
18. Chan CCK, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001; 85:1061-1064. (Pubitemid 32835392)
19. Chan CCK, O'Day J. Oral and intravenous steroids in giant cell arteritis. Clin Exper Ophthalmol. 2003;31:179-182. (Pubitemid 36833365)